Molina Healthcare Awarded New Florida Medicaid Contract
Under the contract award in Miami-Dade and Monroe Counties, Molina expects to serve approximately 90,000 Medicaid beneficiaries.
Will High Medical Care Costs Hurt Molina's (MOH) Q2 Earnings?
Molina Healthcare, Inc. (MOH Quick QuoteMOH - Free Report) is slated to report second-quarter 2024 results on Jul 24, after market close.
BofA Downgrades Elevance Health On Medicaid Pressure And Lowered Peer Valuations
Wednesday, Elevance Health Inc. (NYSE:ELV) reported second-quarter revenues of $43.2 billion, down 0.4% year-over-year, marginally above the consensus of $43.05 billion. The decrease was driven by
Elevance Extends Losses as BofA Cuts on Medicaid Headwinds
Elevance Health Shares Tumble on Indication of Rising Medical Costs
Express News | Shares of Molina Down 3%, Centene Down 3.8%
Molina Healthcare's (NYSE:MOH) Five-year Total Shareholder Returns Outpace the Underlying Earnings Growth
While Molina Healthcare, Inc. (NYSE:MOH) shareholders are probably generally happy, the stock hasn't had particularly good run recently, with the share price falling 21% in the last quarter. But
Molina Healthcare Up Over 5%, on Pace for Largest Percent Increase Since April 2023 -- Data Talk
Molina Healthcare, Inc. (MOH) is currently at $299.68, up $15.71 or 5.53% --Would be highest close since June 27, 2024, when it closed at $302.83 --On pace for largest percent increase since April 27,
Express News | Shares of Health Insurers Are Trading Higher in Sympathy With UnitedHealth, Which Gained Following Strong Q2 Earnings
Express News | Centene Shares Rise 2.1%, Cigna Group Shares up 1.3%, CVS Health Shares up About 1%
Express News | Humana Shares up 3.6%, Elevance Health Shares up 2.3%, Molina Shares up 2.1%
Key Takeaways From Molina Healthcare Analyst Ratings
8 analysts have expressed a variety of opinions on Molina Healthcare (NYSE:MOH) over the past quarter, offering a diverse set of opinions from bullish to bearish.In the table below, you'll find a
Express News | Truist Securities Maintains Buy on Molina Healthcare, Lowers Price Target to $400
Truist Financial Maintains Molina Healthcare(MOH.US) With Buy Rating, Cuts Target Price to $400
Truist Financial analyst David S Macdonald maintains $Molina Healthcare(MOH.US)$ with a buy rating, and adjusts the target price from $440 to $400.According to TipRanks data, the analyst has a
Analysts Conflicted on These Healthcare Names: Daiichi Sankyo Company (OtherDSKYF), Inovio Pharmaceuticals (INO) and Molina Healthcare (MOH)
Express News | Molina Healthcare Inc : Truist Securities Cuts Target Price to $400 From $440
Express News | Molina Healthcare Inc : Mizuho Cuts Target Price to $350 From $415
Mastercard Chair Merit Janow, Molina Healthcare's Dale Wolf, Board Advisor Ram Charan and CBM Founder TK Kerstetter Honored With 2024 Board Leadership Awards
Merit Janow, chair of the board at Mastercard was named "Independent Director of the Year" today by Corporate Board Member as part of the magazine's...
Molina Healthcare Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/10/2024 38.68% JP Morgan $420 → $395 Maintains Overweight 05/30/2024 47.46% JP Morgan $435 → $420
JPMorgan Adjusts Price Target on Molina Healthcare to $395 From $420
Molina Healthcare (MOH) has an average outperform rating and a price target range of $320 to $442, according to analysts polled by Capital IQ.Price: 287.89, Change: +0.59, Percent Change: +0.21